TRIALJECTORY
TrialJectory is an AI-based clinical trial-matching platform that uses self-reported clinical information to facilitate the clinical trial search and enrollment by cancer patients and their physicians. The Company partners with all sectors of the health industry to revolutionize the trial recruitment process, leading to reduced operational costs and expedited drugs' time to market.
TRIALJECTORY
Industry:
Communities Health Care Marketplace
Founded:
2017-12-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.trialjectory.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
27.72 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Nginx Amazon Google Maps Person Schema Google Google Maps API Google Cloud Facebook Sharer
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Mable
Mable is an online platform where people with disability, or those who are aging, can find and hire local care and support workers.
Imagia
Imagia is the indispensable AI healthcare partner for pharma, medical devices and clinical providers.
LunaPBC
LunaPBC is a healthcare company that transforms health data into health breakthroughs.
Sema4
Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Current Advisors List
Current Employees Featured
Founder
Investors List
JAL Ventures
JAL Ventures investment in Series A - TrialJectory
Contour Venture Partners
Contour Venture Partners investment in Series A - TrialJectory
TIA Ventures
TIA Ventures investment in Series A - TrialJectory
Insight Partners
Insight Partners investment in Series A - TrialJectory
Rho Ventures
Rho Ventures investment in Series A - TrialJectory
Rho Ventures
Rho Ventures investment in Series A - TrialJectory
Contour Venture Partners
Contour Venture Partners investment in Series A - TrialJectory
TIA Ventures
TIA Ventures investment in Series A - TrialJectory
Connecticut Innovations
Connecticut Innovations investment in Series A - TrialJectory
Contour Venture Partners
Contour Venture Partners investment in Seed Round - TrialJectory
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-06 | Trialjectory Appoints Gregory T. Simpson as Chief Marketing Officer |
Official Site Inspections
http://www.trialjectory.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.31 K
- Host name: ec2-18-209-211-122.compute-1.amazonaws.com
- IP address: 18.209.211.122
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "TrialJectory"
TrialJectory - The Org
TrialJectory is a patient-first digital health company with a mission to democratize access to advanced cancer treatment. We use artificial intelligence (AI) to empower patients to own their cancer journey and analyze our global patient …See details»
Leal Health - Crunchbase Company Profile & Funding
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. …See details»
Trialjectory Raises $20 Million to Transform the Cancer Care Industry
NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Trialjectory ("the Company"), the AI-powered decision-support platform for patients, health-care providers and pharma, announced today …See details»
MPN Research Foundation and Trialjectory Partner to Provide …
New York, N.Y., May 10, 2022 – MPN Research Foundation (MPNRF), a global organization driving research to find new and better treatments for myeloproliferative neoplasms (MPNs), a …See details»
Israeli-US Startup Harnesses AI To Help Cancer Patients …
Oct 10, 2018 Trialjectory, with offices in Tel Aviv and New York, launched a unique service that connects cancer sufferers with clinical trials that are …See details»
Trialjectory Grows Pharmaceutical and Biotech Clinical Trial ...
Dec 5, 2022 Trialjectory is a patient-first, AI-powered decision support platform dedicated to improving cancer treatment. Working directly with patients, healthcare providers and …See details»
TrialJectory (USA) Funding: $27.7M - medicalstartups.org
TrialJectory's mission is to use AI to transform the world of cancer care. By being the leading personalised, AI-based clinical trials data platform, the company partners with industry leaders …See details»
Trialjectory scores $20M to match cancer patients to …
Feb 7, 2022 "Trialjectory's model fosters a high-level of engagement with cancer patients. These trusted relationships, combined with the robust data and insight we provide pharma, [create] a new opportunity to position the patient as a …See details»
TrialJectory hauls in $20M series A money to boost AI health …
Feb 7, 2022 TrialJectory, a New York-based group that builds health support platforms, has hauled in $20 million in series A financing to bolster its AI-powered technology.. The funds will …See details»
TrialJectory - Democratization of Advanced Treatments - LinkedIn
May 15, 2019 TrialJectory is an AI-based marketplace that helps remove barriers between the patient community, oncologists and pharmaceutical companies. We help bridge the gap …See details»
TrialJectory - StartupHub.ai
Leal Health is an AI-powered decision-making support platform that expedites access to advanced cancer treatments and empowers pharmaceutical companies to develop patient-centric clinical trials. TrialJectory is another healthcare …See details»
Tzvia Bader on the TrialJectory Clinical Trial Tool - Cancer Network
Aug 25, 2020 A cancer survivor herself, Tzvia Bader, chief executive officer and co-founder of TrialJectory, also developed the platform to give pharmaceutical companies transparency into …See details»
Trialjectory - Overview, News & Similar companies - ZoomInfo
Aug 7, 2023 Who is Trialjectory. TrialJectory is a patient-first digital health company with a mission to democratize access to advanced cancer treatment. TrialJectory uses artific ial …See details»
Trialjectory Raises $20 Million to Transform the Cancer Care Industry
NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Trialjectory ("the Company"), the AI-powered decision-support platform for patients, health-care providers and pharma, announced today …See details»
Oncology Peer Review On-The-Go: Improving Testing Access and …
Dec 7, 2021 This week’s conversation focuses on TrialJectory, a digital health company that utilizes artificial intelligence to help guide patients with cancer on their treatment journey. …See details»
TrialJectory and OncoBay Clinical Partner to Connect All Cancer ...
New York, N.Y., and Tampa, Fla. – September30,2020– TrialJectory, an AI-powered technology platform that empowers cancer patients to find advanced new treatment options that fit their …See details»
TrialJectory raises funds to expand patient access to clinical trials
Dec 18, 2019 The company currently supports trials for breast cancer, colon cancer, bladder cancer, melanoma and myelodysplastic syndromes (MDS). Lead investor Bob Greene said: …See details»
AI is secret weapon for cancer trial recruitment and engagement
Jun 6, 2022 TrialJectory shared the research in a poster presentation at the American Society of Clinical Oncology (ASCO) annual meeting this week, explaining that its AI-based approach …See details»
Trialjectory: A short introduction - Colontown University
Trialjectory provides a clinical trial matching service. Patients answer a detailed questionnaire about their diagnosis, treatment, and preferences for enrolling in a clinical trial (such as …See details»
TrialJectory DMF, CEP, Written Confirmations, FDF, Prices, Patents ...
TrialJectory// Our mission is to use AI to transform the world of cancer care. By being the leading personalised, AI-based clinical trial data platform, we partner with industry leaders to expedite …See details»